From: The quality of reporting of randomized controlled trials of electroacupuncture for stroke
Included Trials | Publicati-on language | Type of stroke | Study designs | Sample size calculation | No. of Participants (male/female); age(y) | Course of disease | Interventions(n)Drug/dosage | Course of treatment | ||
---|---|---|---|---|---|---|---|---|---|---|
Trial | Control | Trial | Control | |||||||
Cao 2012 [14] | Chinese | infarction | RCT | No | 40(22/18); 57.5 ± 9.8 | 40(24/16); 57.2 ± 9.5 | <3d | electro-scalp-body-Ac | WCTs* (general supportive care, antiplatelet agents, neuroprotective agents, treatment of acute complications) | 4w |
Chen 2001 [15] | English | infarction | RCT | No | 21(14/7); Mean 64.8 | 16(10/6); Mean 66.1 | <3d | electro-scalp-body-Ac + WCTs# | WCTs*(specialized care) | 4w |
Chen 2010 [16] | Chinese | infarction | RCT | No | 40 (27/13); Mean 54.4 | 38(28/10); Mean 55.4 | ≤7d | electro-body-Ac + WCTs# | WCTs* (general supportive care, antiplatelet agents, anticoagulants, neuroprotective agents) | 4w |
Chen C L (Unpublished Master’s thesis, 2008) [17] | Chinese | infarction ICH | RCT | No | 32(20/12); 50–75 | 32(18/14); 50–75 | <6 m | electro-body-Ac + WCTs# | Ac + WCTs* (general supportive care, specialized care, stroke rehabilitation) | 4w |
Dong 2011 [18] | Chinese | infarction ICH | RCT | No | 75(45/30); Mean 67 | 75(48/27); Mean 65 | <2w | electro-body-Ac + WCTs# | WCTs* (, stroke rehabilitation) | 10d |
Er 2010 [19] | Chinese | infarction ICH | RCT | No | 30(16/14); Mean 54.2 | 30(18/12); Mean 56.1 | 1 m–3 m | electro-body-Ac + WCTs# | WCTs* (stroke rehabilitation) | 6w |
Fu 2010 [20] | Chinese | infarction | RCT | No | 80(41/39); Mean 62.8 | 80(43/37); Mean 63.3 | <1 m | electro-body-Ac + WCTs# | WCTs* (general supportive care, antiplatelet agents aspirin 0.1 g po qd, treatment of acute complications, stroke rehabilitation) | 4w |
Gao 2012 [21] | Chinese | infarction | RCT | No | 82(45/37); Mean 62.4 | 78(42/36); Mean 62.7 | 3–74d | electro-scalp-body-Ac + WCTs# | WCTs* (antiplatelet agents aspirin 0.1 g po qd,) | 4w |
Gong 2008 [22] | Chinese | infarction; ICH | RCT | No | 32 (15/17); Mean 52 | 31(16/15); Mean 51.4 | Mean 36–38d | electro-body-Ac + WCTs# | WCTs*(stroke rehabilitation) | 6w |
Gosman-Hedstrom 1998 [23] | English | infarction | RCT | No | 37(20/17); Mean 76.1 | 33(9/24); Mean 76.9 | <7d | electro-scalp-body-Ac + WCTs# | WCTs*(stroke rehabilitation) | 4w |
Gosman-Hedstrom 1998 [23] | English | infarction | RCT | No | 37(20/17); Mean 76.1 | 34(17/17); Mean 79 | <7d | electro-scalp-body-Ac + WCTs# | Sham Ac + WCTs* (stroke rehabilitation) | 10w |
Guo 2009 [24] | Chinese | infarction | RCT | No | 30(17/13); Mean 56.3 | 30(21/9); Mean 55.6 | <7d | electro-body-Ac + WCTs# | WCTs* (antiplatelet agents aspirin 0.3 g po qd, a week later recuced to 0.1 g po qd, stroke rehabilitation) | 14d |
Hopwood 2008 [25] | English | Infarction; ICH | RCT | No | 57(19/38); Mean 70.5 | 48(26/22); Mean 74.4 | 4–10d | electro-scalp-body-Ac | Sham Ac | 4w |
Hsing 2012 [26] | English | infarction | RCT | No | 35; Mean 50 | 27; Mean 52 | >18Â m | electro-scalp-Ac | Sham Ac | 5w |
Hsieh 2007 [27] | English | infarction | RCT | No | 30(12/18); Mean 68.8 | 33(20/13); Mean 70.7 | <2w | electro-body-Ac + WCTs# | WCTs* (stroke rehabilitation) | 4w |
Hu 1993 [28] | English | infarction | RCT | No | 15(15/0); 63.6 ± 6.7 | 15(13/2); 62.8 ± 8.0 | <36 h | electro-scalp-body-Ac + WCTs# | WCTs* (general supportive care, stroke rehabilitation) | 4w |
Huang 2008 [29] | Chinese | infarction | RCT | No | 40(21/19); Mean 63.6 | 40(20/20); Mean 59.9 | 14–90d | electro-body-Ac + WCTs# | WCTs* + ENS | 4w |
Huang 2011 [30] | Chinese | infarction ICH | RCT | No | 35(22/13); Mean 63.2 | 35(19/16); Mean 65.3 | Mean 7.3–8.1d | electro-scalp-body-Ac | Ac | 6w |
Huang 2012 [31] | Chinese | infarction | RCT | No | 32(12/20) 66.59 ± 10.482; | 26(16/10) 68.92 ± 10.53 | <6d | electro-body-Ac + WCTs# | WCTs* (general supportive care) | 4w |
Jahansson 1993 [32] | English | infarction | RCT | No | 38; Mean 76 | 40; Mean 75 | <10d | electro-body-Ac + WCTs# | WCTs* (stroke rehabilitation) | 10w |
Jahansson 2001 [33] | English | infarction | RCT | Yes | 48(29/19); Mean 76 | 51(25/26); Mean 76 | <10d | electro-scalp-body-Ac + WCTs# | sham Ac + WCTs* (antiplatelet agents, anticoagulants, stroke rehabilitation) | 10w |
Jin 1999 [34] | Chinese | infarction | RCT | No | 60; Mean 68 | 60; Mean 68 | <1 m | electro-scalp-body-Ac + WCTs# | WCTs* (specialized care) | 6w |
Jiu 2008 [35] | Chinese | infarction ICH | RCT | No | 40(23/17); Mean 62.7 | 40(22/18); Mean 63 | <2w | Electro-body-Ac + WCTs# | WCTs* (stroke rehabilitation) | 2 m |
Lei2013 [36] | Chinese | infarction ICH | RCT | No | 40(19/21); 48-61 | 40(25/15); 43–64 | 4–31 m | electro-body-Ac + WCTs# | WCTs* (general supportive care, stroke rehabilitation) | 4w |
Li 2006 [37] | Chinese | infarction | RCT | No | 52(34/18); 66.8 ± 4.7 | 50(35/15); 67.1 ± 3.9 | <1 m | electro-scalp-body-Ac + WCTs# | WCTs* (general supportive care) | 3w |
Li 2011 [38] | Chinese | infarction | RCT | No | 30(14/16) Mean 54.4 | 30(13/17) Mean 55.4 | <1 m | electro-body-Ac + WCTs# | WCTs* (treatment of acute complications, stroke rehabilitation) | 4w |
Li X Z (unpublished Master’s thesis, 2005) [39] | Chinese | infarction | RCT | No | 35(18/17); Mean 61.5 | 35(20/15); Mean 59.7 | <3d | electro-scalp-Ac + WCTs# | WCTs* (general supportive care, anticoagulantslow molecular heparin, treatment of acute complications) | 10d |
Liu 2007 [40] | Chinese | infarction ICH | RCT | No | 38(25/13); Mean 59.4 | 37(14/23); Mean 56.4 | <2w | Electro-body-Ac + WCTs# | WCTs* (specialized care, stroke rehabilitation) | 3w |
Liu 2010 [41] | Chinese | infarction ICH | RCT | No | 50(32/18); Mean 61 | 50(35/15); Mean 63 | 2d–6 m | electro-scalp-Ac + WCTs# | WCTs* (stroke rehabilitation) | 1 m |
Long 2004 [42] | Chinese | infarction ICH | RCT | No | 43(30/13); Mean 60 | 41(27/14); Mean 62 | <7d | electro-scalp-body-Ac + WCTs# | WCTs* | 7w |
Luo 2012 [43] | Chinese | infarction ICH | RCT | No | 10(5/5); Mean 60.5 | 9(5/4); Mean 62.3 | 2w–1 m | electro-body-Ac + WCTs# | WCTs* (stroke rehabilitation) | 6w |
Lv 2003 [44] | Chinese | infarction | RCT | No | 29; 52–79 | 26; 52–79 | <5d | electro-scalp-body-Ac + WCTs# | WCTs* (general supportive care, volume expansion and vasodilators, neuroprotective agents, treatment of acute complications) | 1 m |
Naeser 1992 [45] | English | infarction | RCT | No | 10 | 6 | 1–3 m | electro-scalp-body-Ac | Sham Ac | 4w |
Pei2001 [46] | English | infarction | RCT | No | 43(28/15); Mean 71.6 | 43(24/19); Mean 69.3 | <7d | electro-scalp-body-Ac + WCTs# | WCTs* | 4w |
Peng 2007 [47] | Chinese | infarction | RCT | No | 40; Mean 54 | 40; Mean 54 | ≤7d | electro-body-Ac + WCTs# | WCTs* (general supportive care, stroke rehabilitation) | 12w |
Peng 2009 [48] | Chinese | infarction ICH | RCT | No | 30; 18–70 | 30; 18–70 | Mean 2–3 m | electro-scalp-body-Ac | Ac | 45d |
Qi 2012 [49] | Chinese | Cerebral vascular disease | RCT | No | 39(20/19); 60.12 ± 6.34 | 39(19/20); 60.23 ± 6.45 | <12 m | electro–du-meridian-Ac | manual-body-Ac | 20d |
Sallstrom 1996 [50] | English | infarction ICH | RCT | No | 26; Median 57 | 23; Median 58 | 15–71d | electro-scalp-body-Ac + WCTs# | WCTs* (stroke rehabilitation) | 6w |
Sang 2011 [51] | Chinese | infarction | RCT | No | 40; 38–75 | 40; 38–75 | <7d | electro-body-Ac + WCTs# | WCTs* (neuroprotective agents cerebrolysin vial 30 ml ivgtt qd, treatment of acute complications) | 14d |
Schaechter2007 [52] | English | infarction | RCT | No | 4(3/1); 28–80 | 4 | 1–10.2y | electro-scalp-body-Ac | Sham Ac | 10w |
Schuler 2005 [53] | English | infarction | RCT | No | 41; Mean 77.5 | 40; Mean 78.7 | 3–35d | scalp-body-Ac | Sham Ac | 4w |
Si 1998 [54] | English | infarction | RCT | No | 20(15/5); 68 ± 10 | 22(18/4); 67 ± 8 | <7d | electro-scalp-body-Ac + WCTs# | WCTs* (specialized care) | 7d |
Su 2002 [55] | Chinese | infarction ICH | RCT | No | 43(27/16); 58 ± 4 | 40(23/17); 57 ± 5 | <12 m | electro-body-Ac + WCTs# | WCTs* (general supportive care, stroke rehabilitation) | 20-30d |
Sun 2005 [56] | Chinese | infarction | RCT | No | 40(27/13) | 43(29/14) | <12 h | electro-scalp-Ac + WCTs# | WCTs* (specialized care) | 12d |
Sun 2012 [57] | Chinese | infarction | RCT | No | 35(23/12); Mean 57.5 | 35(17/18); Mean 56 | <3d | electro-scalp-body-Ac + WCTs# | WCTs* (specialized care) | 14d |
Wang 1998 [58] | Chinese | infarction | RCT | No | 80; Mean 68 | 80; Mean 68 | Mean 24d | electro-scalp-body-Ac + WCTs# | WCTs* | 20d |
Wang 2001 [59] | Chinese | infarction ICH | RCT | No | 106; 35–80 | 54; 35–80; | <1y | Electro-body-Ac | Ac | 6w |
Wang 2003 [60] | Chinese | infarction ICH | RCT | No | 32; 46–77 | 32; 46–77 | <14d | electro-body-Ac + WCTs# | WCTs* | 20d |
Wang 2008 [61] | Chinese | ICH | RCT | No | 45(30/15); Mean 62 | 45(29/16); Mean 63 | <7d | electro-scalp-body-Ac + WCTs# | WCTs* (general supportive care, specialized care) | 4w |
Wang 2009 [62] | Chinese | infarction | Quasi-RCT | No | 65(33/32); Mean 72.2 | 50(26/24); Mean 70.1 | ≤3d | electro-body-Ac + WCTs# | ENS + WCTs* (antiplatelet agents aspirin 0.1 g po qd, stroke rehabilitation) | 4w |
Wang Q (unpublished Master’s thesis, 2009) [63] | Chinese | infarction | RCT | Yes | 24(15/9); Mean 62.4 | 22(14/8) Mean 57.1 | <2w | electro-body-Ac + WCTs# | WCTs*(general supportive care) | 4w |
Wang X W (unpublished Master’s thesis, 2011) [64] | Chinese | infarction | RCT | No | 31(17/14) Mean 57.4 | 30(19/11) Mean 60.3 | <3d | electro-body-Ac + WCTs# | WCTs* (general supportive care, antiplatelet agents aspirin 0.1 g po qd, treatment of acute complications) | 14d |
Wayne 2005 [65] | English | infarction ICH | RCT | No | 16(12/4); 38–89 | 17(12/5); 42–69 | >6 m | electro-scalp-body-Ac | Sham Ac | 10w |
Wei 2008 [66] | Chinese | infarction ICH | RCT | No | 46(29/17); Mean 59.4 | 44(23/21); Mean 56.4 | 2–7d | electro-body-Ac + WCTs# | WCTs* (general supportive care, specialized care, stroke rehabilitation) | 5w |
Wong 1999 [67] | English | infarction ICH | RCT | No | 59(38/21); Mean 60.4 | 59(42/17); Mean 60.6 | <14d | electro-body-Ac + WCTs# | WCTs* | 2w |
Wu 2008 [68] | Chinese | infarction ICH | RCT | No | 30; 46–75 | 30; 46–75 | >1 m | electro-body-Ac + WCTs# | WCTs* (stroke rehabilitation) | 30d |
Wu 2009 [69] | Chinese | infarction | RCT | No | 29(16/13); Mean 56.7 | 29(17/12); Mean 58.5 | <14d | electro-body-Ac + WCTs# | WCTs* (general supportive care, specialized care, antiplatelet agents aspirin 0.1 g po qd) | 14d |
Wu 2011 [70] | Chinese | infarction ICH | RCT | No | 30(18/12) | 30(19/11) | >3w | electro-body-Ac + WCTs# | WCTs* (general supportive care, specialized care, stroke rehabilitation) | 6w |
WuXL 2008 [71] | Chinese | infarction | RCT | No | 32(20/12); Mean 67.2 | 29(19/10); Mean 66.6 | <7d | electro-scalp-body-Ac + WCTs# | WCTs* + Ac | 3 m |
Xue 2007 [72] | Chinese | infarction; ICH | RCT | No | 18(14/4); Mean 66.1 | 18(15/3); Mean 64.2 | <2w | electro-body-Ac + WCTs# | WCTs* (stroke rehabilitation) | 4w |
Yu 2005 [73] | Chinese | infarction | RCT | No | 16(10/6); 40–76 | 14(8/6); 40–75 | <3d | electro-scalp-body-Ac + WCTs# | WCTs* (vasodilators, neuroprotective agents) | 2w |
Yue 2012 [74] | Chinese | infarction ICH | RCT | No | 33(21/12); Mean 70.4 | 31(18/13); Mean 69.8 | 80-163d | electro-body-Ac | Ac | 1Â m |
Zhang 1995 [75] | Chinese | infarction | RCT | No | 40(23/17); Mean 65.8 | 40(22/18); Mean 68.7 | <7d | electro-scalp-Ac + WCTs# | WCTs* (specialized care) | 20d |
Zhang 2006 [76] | Chinese | infarction ICH | RCT | No | 32(17/15); Mean 62.7 | 25(15/10); Mean 64.5 | <6 m | electro-body-Ac + WCTs# | WCTs* + Ac | 30d |
Zhang 2008 [77] | Chinese | infarction ICH | RCT | No | 49(26/23) Mean 51.5 | 49(24/25) Mean 54.7 | <2w | Electro-body-Ac + WCTs# | WCTs* (general supportive care, specialized care, stroke rehabilitation) | 2 m |
Zhang 2009 [78] | Chinese | infarction ICH | RCT | No | 30(12/18); Mean 55.7 | 30(15/15); Mean 58.4 | <3y | Electro-body-Ac + WCTs# | WCTs*(stroke rehabilitation) | 1 m |
Zhang 2013 [79] | Chinese | infarction | Quasi-RCT | No | 45(27/18); Mean 65.5 | 45(30/15); Mean 63.2 | <3d | electro-scalp-body-Ac + WCTs# | WCTs* (general supportive care, specialized care, neuroprotective agents) | 4w |
Zhang SS (unpublished Master’s thesis, 2009) [80] | Chinese | infarction | RCT | No | 29(17/12); Mean 62.9 | 29(16/13); Mean 63.6 | <10d | electro-body-Ac + WCTs# | WCTs* (general supportive care, treatment of acute complications, stroke rehabilitation) | 3w |
Zhang X, (unpublished Master’s thesis, 2008) [81] | Chinese | infarction | RCT | No | 60(33/27); 40–80 | 30(17/13); 40–80 | <2w | electro-body-Ac + WCTs# | WCTs* (general supportive care, antiplatelet agents aspirin 0.1 g po qd, treatment of acute complications, stroke rehabilitation) | 2w |
Zhao 2005 [82] | Chinese | infarction ICH | RCT | No | 60(36/24); Mean 63.0 | 60(31/29); Mean 67.4 | <2w | electro-scalp-body-Ac + WCTs# | WCTs* (general supportive care, specialized care, (treatment of acute complications, stroke rehabilitation) | 1 m |
Zhu 2012 [83] | Chinese | infarction ICH | RCT | No | 40; 32–69 | 40; 32–69 | <2w | Electro-body-Ac + WCTs# | WCTs* (general supportive care, specialized care) | 1 m |